Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 28, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 28, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 480 Common Stock at $514.26 ($246,843) on August 28, 2026; holds 333,463 after (Indirect).
- Open-market sale: disposed of 1,630 Common Stock at $515.46 ($840,198) on August 28, 2026; holds 331,833 after (Indirect).
- Open-market sale: disposed of 2,386 Common Stock at $516.16 ($1,231,551) on August 28, 2026; holds 329,447 after (Indirect).
- Open-market sale: disposed of 1,486 Common Stock at $517.11 ($768,421) on August 28, 2026; holds 327,961 after (Indirect).
- Open-market sale: disposed of 1,346 Common Stock at $518.14 ($697,421) on August 28, 2026; holds 326,615 after (Indirect).
- Open-market sale: disposed of 412 Common Stock at $519.19 ($213,907) on August 28, 2026; holds 326,203 after (Indirect).
- Open-market sale: disposed of 751 Common Stock at $520.30 ($390,743) on August 28, 2026; holds 325,452 after (Indirect).
- Open-market sale: disposed of 286 Common Stock at $521.58 ($149,172) on August 28, 2026; holds 325,166 after (Indirect).
- Open-market sale: disposed of 517 Common Stock at $522.40 ($270,082) on August 28, 2026; holds 324,649 after (Indirect).
- Open-market sale: disposed of 6 Common Stock at $523.42 ($3,141) on August 28, 2026; holds 324,643 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $524.42 ($104,884) on August 28, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 28, 2026; holds 37,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,916,363 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-28 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-28 | Open-market sale | Common Stock | 480 | $514 | $246.8K | 333,463 |
| 2026-08-28 | Open-market sale | Common Stock | 1,630 | $515 | $840.2K | 331,833 |
| 2026-08-28 | Open-market sale | Common Stock | 2,386 | $516 | $1.2M | 329,447 |
| 2026-08-28 | Open-market sale | Common Stock | 1,486 | $517 | $768.4K | 327,961 |
| 2026-08-28 | Open-market sale | Common Stock | 1,346 | $518 | $697.4K | 326,615 |
| 2026-08-28 | Open-market sale | Common Stock | 412 | $519 | $213.9K | 326,203 |
| 2026-08-28 | Open-market sale | Common Stock | 751 | $520 | $390.7K | 325,452 |
| 2026-08-28 | Open-market sale | Common Stock | 286 | $522 | $149.2K | 325,166 |
| 2026-08-28 | Open-market sale | Common Stock | 517 | $522 | $270.1K | 324,649 |
| 2026-08-28 | Open-market sale | Common Stock | 6 | $523 | $3.1K | 324,643 |
| 2026-08-28 | Open-market sale | Common Stock | 200 | $524 | $104.9K | 324,443 |
| 2026-08-28 | Option exercise/conversion | Stock Option | 9,500 | — | — | 37,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-28 | Option exercise/conversion (9,500 shares) |
| 2026-08-28 | Open-market sale (480 shares) |
| 2026-08-28 | Open-market sale (1,630 shares) |
| 2026-08-28 | Open-market sale (2,386 shares) |
| 2026-08-28 | Open-market sale (1,486 shares) |
| 2026-08-28 | Open-market sale (1,346 shares) |
| 2026-08-28 | Open-market sale (412 shares) |
| 2026-08-28 | Open-market sale (751 shares) |
| 2026-08-28 | Open-market sale (286 shares) |
| 2026-08-28 | Open-market sale (517 shares) |
| 2026-08-28 | Open-market sale (6 shares) |
| 2026-08-28 | Open-market sale (200 shares) |
| 2026-08-28 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.